Protective Efficacy and Immunogenicity of a Combinatory DNA Vaccine against Influenza A Virus and the Respiratory Syncytial Virus
Open Access
- 14 August 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (8) , e72217
Abstract
The Respiratory Syncytial Virus (RSV) and Influenza A Virus (IAV) are both two major causative agents of severe respiratory tract infections in humans leading to hospitalization and thousands of deaths each year. In this study, we evaluated the immunogenicity and efficacy of a combinatory DNA vaccine in comparison to the single component vaccines against both diseases in a mouse model. Intramuscular electroporation with plasmids expressing the hemagglutinin (HA) of IAV and the F protein of RSV induced strong humoral immune responses regardless if they were delivered in combination or alone. In consequence, high neutralizing antibody titers were detected, which conferred protection against a lethal challenge with IAV. Furthermore, the viral load in the lungs after a RSV infection could be dramatically reduced in vaccinated mice. Concurrently, substantial amounts of antigen-specific, polyfunctional CD8+ T-cells were measured after vaccination. Interestingly, the cellular response to the hemagglutinin was significantly reduced in the presence of the RSV-F encoding plasmid, but not vice versa. Although these results indicate a suppressive effect of the RSV-F protein, the protective efficacy of the combinatory vaccine was comparable to the efficacy of both single-component vaccines. In conclusion, the novel combinatory vaccine against RSV and IAV may have great potential to reduce the rate of severe respiratory tract infections in humans without increasing the number of necessary vaccinations.Keywords
This publication has 41 references indexed in Scilit:
- Clinical Applications of DNA Vaccines: Current ProgressClinical Infectious Diseases, 2011
- Broad Humoral and Cellular Immunity Elicited by a Bivalent DNA Vaccine Encoding HA and NP Genes from an H5N1 VirusViral Immunology, 2011
- Controlling Influenza by Cytotoxic T-Cells: Calling for Help from DestroyersJournal of Biomedicine and Biotechnology, 2010
- Protective Efficacy and Immunogenicity of an Adenoviral Vector Vaccine Encoding the Codon-Optimized F Protein of Respiratory Syncytial VirusJournal of Virology, 2009
- DNA vaccines: ready for prime time?Nature Reviews Genetics, 2008
- Enhancement of the CD8+ T cell response to a subdominant epitope of respiratory syncytial virus by deletion of an immunodominant epitopeVaccine, 2008
- Coexpression of GM-CSF and antigen in DNA prime-adenoviral vector boost immunization enhances polyfunctional CD8+ T cell responses, whereas expression of GM-CSF antigen fusion protein induces autoimmunityBMC Immunology, 2008
- Amino Acid Similarity Accounts for T Cell Cross-Reactivity and for “Holes” in the T Cell RepertoirePLOS ONE, 2008
- Generation and application of new rat monoclonal antibodies against synthetic FLAG and OLLAS tags for improved immunodetectionJournal of Immunological Methods, 2008
- Expression of RNA virus proteins by RNA polymerase II dependent expression plasmids is hindered at multiple stepsVirology Journal, 2007